- Home
- GAIN vs LAB Comparison
GAIN vs LAB Comparison
Compare GAIN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIN
- LAB
- Stock Information
- Founded
- GAIN 2005
- LAB 1999
- Country
- GAIN United States
- LAB United States
- Employees
- GAIN N/A
- LAB N/A
- Industry
- GAIN Finance: Consumer Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- GAIN Finance
- LAB Industrials
- Exchange
- GAIN Nasdaq
- LAB Nasdaq
- Market Cap
- GAIN 497.3M
- LAB 562.1M
- IPO Year
- GAIN 2005
- LAB 2011
- Fundamental
- Price
- GAIN $13.39
- LAB $1.08
- Analyst Decision
- GAIN Hold
- LAB Strong Buy
- Analyst Count
- GAIN 2
- LAB 3
- Target Price
- GAIN $13.75
- LAB $2.88
- AVG Volume (30 Days)
- GAIN 114.8K
- LAB 1.5M
- Earning Date
- GAIN 05-07-2025
- LAB 05-07-2025
- Dividend Yield
- GAIN 7.18%
- LAB N/A
- EPS Growth
- GAIN N/A
- LAB N/A
- EPS
- GAIN 1.92
- LAB N/A
- Revenue
- GAIN $89,176,000.00
- LAB $174,432,000.00
- Revenue This Year
- GAIN $5.92
- LAB N/A
- Revenue Next Year
- GAIN $10.25
- LAB $12.77
- P/E Ratio
- GAIN $7.10
- LAB N/A
- Revenue Growth
- GAIN 6.78
- LAB 64.03
- 52 Week Low
- GAIN $12.46
- LAB $0.99
- 52 Week High
- GAIN $14.85
- LAB $3.04
- Technical
- Relative Strength Index (RSI)
- GAIN 47.29
- LAB 39.47
- Support Level
- GAIN $13.52
- LAB $1.11
- Resistance Level
- GAIN $13.68
- LAB $1.21
- Average True Range (ATR)
- GAIN 0.18
- LAB 0.07
- MACD
- GAIN 0.01
- LAB 0.01
- Stochastic Oscillator
- GAIN 53.28
- LAB 14.24
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.